Benitec Biopharma Inc. - Common Stock — Cash Flow (NASDAQ:BNTC) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.83 M-15.9 M-18.01 M-19.4 M-23.59 M -19.79 M Cash from investing activities -221 K-13 K-1 000-179 K-18 K -26 K Cash from financing activities 22.52 M22.52 M16.02 M68.03 M70.48 M 101.48 M Free cash flow -12.83 M-15.9 M-18.01 M-19.4 M-23.61 M -19.81 M

News

Benitec BioPharma stock maintains Buy rating on positive trial data

Benitec reports interim results from gene therapy trial

Benitec BioPharma stock rating maintained on gene therapy data

Benitec to present BB-301 gene therapy study results in March

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade

Citizens reiterates Market Outperform rating on Benitec BioPharma stock

Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target

Benitec’s gene therapy shows durable results in OPMD patients

Monday’s Insider Moves: Dolphin CEO’s Big Bet Amid Notable Sells

Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?